Your medical briefing

Stay current.
Stay focused.

Research, guidelines, and safety alerts for your specialty.

All specialties Internal Medicine Family Medicine Pediatrics Cardiology Oncology Endocrinology Surgery

Anesthesiology

Recent updates in Anesthesiology from the last 30 days.

AllAll updates Research Guidelines Safety alerts

This article describes Medicare's Transforming Episode Accountability Model (TEAM), a bundled payment approach running 2026 to 2030 that introduces episode-level accountability for surgical cost and outcomes, replacing fee-for-service for discrete activities. The authors state that anesthesiologist reimbursement is included within the bundle and that anesthesiologists' perioperative decision-making can strongly influence hospital performance under TEAM's risk-sharing arrangements. The article discusses expanded roles for anesthesiologists in preventing complications and optimizing perioperative care, and the growing need to define, measure, and report outcomes reflecting their contribution to recovery and resource utilization.

Stay current.
Stay focused.

Anesthesiology

Medicare's TEAM Bundled Payment Model Reshapes Anesthesiology Practice

Hypothermia delays but does not prevent malignant hyperthermia in mice

Real-time CDS tool increased accurate ASA PS classification

Survey finds lasting distress among anesthesiologists after perioperative catastrophes

Consensus calls for measuring and auditing preoperative fasting times

ADM and AP muscle EMG monitoring show similar overall recovery times

Intrauterine mepivacaine reduces pain during IUD placement in trial

Class I recall: Baxter Healthcare Corporation: Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporat

Short antibiotic course noninferior to long course in orthopedic infection

No Clear Outcome Advantage for Sedation Over General Anesthesia in Thrombectomy

Vagus nerve stimulation lowers rebound pain after shoulder block

Class II recall: Baxter Healthcare Corporation: Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Cont

Class II recall: Baxter Healthcare Corporation: Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/m

Class I recall: OPTIMAL BALANCE PHARMACY: Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutath

Class I recall: Baxter Healthcare Corporation: 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 u

Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in G

Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Sin

IV lidocaine's pain benefit in spine surgery varies by procedure

Review flags inconsistent reporting of indeterminate gastric ultrasound scans

Class I recall: Fresenius Kabi USA, LLC: Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Onl

Stay current. Stay focused.

Stay current.
Stay focused.